SCHEMBL24528856

SCHEMBL24528856

CN(C(=O)OC(C)(C)C)C(c1ccc(CN2CCC(=O)CC2)cc1)C1CC1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
HRH3 Q9Y5N1 1/20 0.35
ACHE P22303 3/20 0.35
BCHE P06276 1/20 0.35
TACR1 P25103 3/20 0.35
ACACB O00763 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TP53 P04637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
BCL2A1 Q16548 1/20 0.34
KCNH2 Q12809 1/20 0.34
MGAT2 Q10469 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24528855 0.89 ALDH1A1 (0.42) KDM4EHRH3ACHEBCHEALDH1A1
SCHEMBL24528848 0.82 L3MBTL3 (0.40) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL24528859 0.77 AAK1 (0.39) SMN1; SMN2BCL2A1
SCHEMBL24528858 0.75 BCL2A1 (0.39) KDM4EALDH1A1HTTBCL2A1
SCHEMBL24528864 0.74 BCL2A1 (0.43) ALDH1A1HTTBCL2A1
SCHEMBL18173436 0.73 KDM1A (0.46) KDM4EHRH3SMN1; SMN2MEN1KMT2A
SCHEMBL2238595 0.68 ALDH1A1 (0.47) KDM4EHRH3ACHEBCHEALDH1A1
SCHEMBL24881010 0.68 KCNH2 (0.48) KDM4EALDH1A1KCNH2
SCHEMBL24881009 0.68 CHRM2 (0.51) KDM4EALDH1A1KCNH2
SCHEMBL803672 0.67 SIGMAR1 (0.59) ACHEBCHEKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116897150-A Novel bifunctional molecules for protein-targeted degradation 安菲斯塔治疗有限公司 2023-10-17 CN disclosed
WO-2022129925-A1 NOVEL BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2022-06-23 WO disclosed